Rate My Professor Emma Vlasiuk

In her current position, Dr Vlasiuk leads clinical studies examining the bioavailability and potential health effects of vitamin C, with a focus on its roles in infection, inflammation, and oxidative stress. Her research assesses vitamin C status and interventions in patients with community-acquired pneumonia, critically ill septic shock, metabolic syndrome, prediabetes, type 2 diabetes mellitus, obesity, severe respiratory infections, and skin health. Key publications include: Vlasiuk, E., et al. (2024). 'SunGold Kiwifruit Consumption Restores Adequate to Optimal Vitamin C Status in People with a History of Severe Respiratory Infections.' Antioxidants, 13(3), 272; Vlasiuk, E., et al. (2024). 'A High Vitamin C Micronutrient Supplement Is Unable to Attenuate Inflammation in People with Metabolic Syndrome but May Improve Metabolic Health Indices: A Randomised Controlled Trial.' Antioxidants, 13(4), 404; Carr, A.C., et al. (2024). 'Understanding the Additional Impact of Prediabetes and Type 2 Diabetes Mellitus on Vitamin C Requirements in People Living with Obesity.' Nutrition Research, 130, 1-10; Crequer, N., et al. (2025). 'Clustering of Community-Acquired Pneumonia in Hospitalised Adults in the Christchurch Region: Association with Socio-Economic Deprivation.' New Zealand Medical Journal, 138(1617), 85-99; Pullar, J.M., et al. (2025). 'Improved Human Skin Vitamin C Levels and Skin Function Following Dietary Intake of Kiwifruit: A High Vitamin C Food.' Journal of Investigative Dermatology (advance online). Earlier contributions cover elevated oxidative stress in septic patients, low vitamin C in pneumonia patients, neutrophil vitamin C uptake, and protein carbonyls in sepsis. Dr Vlasiuk collaborates on randomised controlled trials with Professor Anitra Carr, advancing nutritional strategies for clinical outcomes.